|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent BODY insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why BODY insider buys are important for investors to follow.
Date | Insider | Price | Amount |
12-2-2022 Insider Buy |
Carl Daikeler SEE REMARKS |
$0.70
CAGR »
|
$80,482.51 114,811 shares |
12-2-2022 Insider Buy |
Jonathan Congdon CO-FOUNDER AND VICE CHAIRMAN |
$0.70
CAGR »
|
$175,945.00 250,000 shares |
12-1-2022 Insider Buy |
Carl Daikeler SEE REMARKS |
$0.70
CAGR »
|
$155,000.20 220,456 shares |
11-30-2022 Insider Buy |
Marc Suidan CHIEF FINANCIAL OFFICER |
$0.70
CAGR »
|
$35,000.00 50,000 shares |
11-30-2022 Insider Buy |
Kathy P. Vrabeck CHIEF OPERATING OFFICER |
$0.70
CAGR »
|
$175,250.00 250,000 shares |
6-1-2022 Insider Buy |
Carl Daikeler SEE REMARKS |
$2.20
CAGR »
|
$1,297,451.50 588,800 shares |
5-27-2022 Insider Buy |
Carl Daikeler SEE REMARKS |
$1.92
CAGR »
|
$1,859,208.70 970,226 shares |
5-24-2022 Insider Buy |
Carl Daikeler SEE REMARKS |
$1.55
CAGR »
|
$1,270,691.33 818,974 shares |
5-20-2022 Insider Buy |
Michael Heller Director |
$1.32
CAGR »
|
$297,092.79 224,423 shares |
5-19-2022 Insider Buy |
Jonathan Congdon CO-FOUNDER AND VICE CHAIRMAN |
$1.22
CAGR »
|
$244,590.00 200,000 shares |
5-19-2022 Insider Buy |
Carl Daikeler See Remarks |
$1.18
CAGR »
|
$575,937.59 486,675 shares |
5-17-2022 Insider Buy |
Marc Suidan CHIEF FINANCIAL OFFICER |
$1.10
CAGR »
|
$25,265.50 23,000 shares |
5-18-2022 Insider Buy |
Kathy P. Vrabeck CHIEF OPERATING OFFICER |
$1.07
CAGR »
|
$499,986.61 468,418 shares |
3-7-2013 Insider Buy |
Donna R. Ecton Director |
$7.75
CAGR »
|
$7,750.00 1,000 shares |
9-24-2012 Insider Buy |
David A. Katz Director |
$11.24
CAGR »
|
$11,242.00 1,000 shares |
8-29-2012 Insider Buy |
Donna R. Ecton Director |
$8.90
CAGR »
|
$8,900.00 1,000 shares |
8-27-2012 Insider Buy |
Thomas W. Stoltz COO and CFO |
$8.73
CAGR »
|
$87,300.00 10,000 shares |
8-24-2012 Insider Buy |
Robert Glass Director |
$8.55
CAGR »
|
$50,012.24 5,850 shares |
8-21-2012 Insider Buy |
John K. Haley Director |
$8.55
CAGR »
|
$29,918.00 3,500 shares |
8-21-2012 Insider Buy |
Matthew Swartwood Senior Vice President, Sales |
$8.40
CAGR »
|
$2,520.00 300 shares |
5-8-2012 Insider Buy |
Matthew Swartwood Senior Vice President, Sales |
$14.64
CAGR »
|
$19,915.57 1,360 shares |
5-8-2012 Insider Buy |
Donna R. Ecton Director |
$14.50
CAGR »
|
$14,500.00 1,000 shares |
Also See: Institutional Holders of BODY
Also See: SEC filings
Below we present the annualized performance delivered by BODY stock since 12-2-2022 (the date of the most recent
insider purchase). The performance of the investment from the time BODY insider buying occurred is the ultimate
test of whether insiders were right about BODY being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/05/2022 |
|
End date: |
03/01/2024 |
|
Start price/share: |
$35.55 |
|
End price/share: |
$8.14 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-77.10% |
|
Average Annual Total Return: |
-69.59% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,289.76 |
|
Years: |
1.24 |
|
BODY Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent BODY insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BODY
|
|